Pact Pharma IPO

pactpharma.com

PACT Pharma clinical stage biotechnology company developing personalized adoptive T cell therapies for the eradication of solid tumors.

Founded2017
Total Funding to Date$354.6MM
Register for Details

For more details on financing and valuation for Pact Pharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Pact Pharma Ticker Symbol

Pact Pharma does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Pact Pharma Stock Price

The stock price for Pact Pharma will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Pact Pharma Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
9/30/2022 Series D $104.1MM raised $XXX.XX $XXX.XX
6/15/2020 Series C-1 $50MM raised $XXX.XX $XXX.XX
1/10/2020 Series C $75MM raised $XXX.XX $XXX.XX
5/25/2018 Series B $95.5MM raised $XXX.XX $XXX.XX
12/20/2016 Series A $30MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Pact Pharma in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector